BIOEQUIVALENCE, DOSE-PROPORTIONALITY, AND PHARMACOKINETICS OF NALTREXONE AFTER ORAL-ADMINISTRATION

Google Scholar
  • 1 January 1984
    • journal article
    • research article
    • Vol. 45  (9) , 15-19
Abstract
[Naltrexone is an effective narcotic antagonist which is employed in the treatment of opiate dependence.] Healthy male volunteers (24) participated in a 4-way crossover study to compare the rate and extent of absorption of naltrexone after administration of 50 mg tablets as 50, 100 and 200 mg doses and a 10 mg/ml reference syrup. A high-performance liquid chromatographic method was employed to measure naltrexone and 6-.beta.-naltrexol in plasma and urine. Compared to the syrup the 50 mg tablets were absorbed more slowly but equally well. There was excellent linearity between the administered dose and the area under the plasma concentration-time profile as well as total urinary recovery of both drug and metabolite. The mean half-lives of naltrexone and .beta.-naltrexol were .apprx. 4 and 12 h, respectively. The fraction of drug reaching the systemic circulation was estimated to be 5% of the administered dose because of extensive 1st-pass metanbolism. Less than 1% of the dose was excreted in the urine as naltrexone after 48 h while 25% was recovered as unconjugated .beta.-naltrexol. The renal clearance of naltrexone and .beta.-naltrexol was .apprx. 127 ml/min and 283 ml/min, respectively. The total systemic clearance for naltrexone was .apprx. 94 l/h.